| Breakdown | TTM | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.38B | 10.21B | 9.96B | 9.45B | 8.82B | 8.61B |
| Gross Profit | 4.88B | 5.20B | 4.91B | 4.81B | 4.60B | 4.47B |
| EBITDA | 2.47B | 782.60M | 3.08B | 1.17B | 1.00B | 3.22B |
| Net Income | 1.11B | -81.40M | 1.73B | -71.00M | -40.40M | 2.00B |
Balance Sheet | ||||||
| Total Assets | 21.68B | 21.65B | 25.69B | 24.66B | 25.86B | 27.10B |
| Cash, Cash Equivalents and Short-Term Investments | 152.40M | 68.10M | 152.40M | 133.50M | 199.40M | 460.60M |
| Total Debt | 10.66B | 12.11B | 12.56B | 12.96B | 10.95B | 10.98B |
| Total Liabilities | 13.68B | 14.52B | 15.63B | 15.93B | 13.81B | 13.18B |
| Stockholders Equity | 7.71B | 6.88B | 9.74B | 8.41B | 11.73B | 13.60B |
Cash Flow | ||||||
| Free Cash Flow | 1.76B | 1.94B | 1.51B | 1.72B | 1.68B | 1.94B |
| Operating Cash Flow | 2.70B | 3.15B | 2.78B | 2.76B | 2.71B | 2.81B |
| Investing Cash Flow | 353.50M | -974.80M | -1.29B | -999.40M | -1.04B | -87.90M |
| Financing Cash Flow | -2.98B | -2.26B | -1.47B | -1.82B | -1.93B | -2.35B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | $45.15B | 13.63 | 16.90% | 8.22% | -0.68% | 4.29% | |
70 Outperform | $2.34B | 19.30 | 12.16% | ― | -1.13% | 24.34% | |
67 Neutral | $26.28B | 11.96 | 15.12% | 2.92% | -5.57% | 119.49% | |
63 Neutral | $10.84B | 12.09 | 19.93% | 3.42% | -4.59% | -19.19% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
60 Neutral | $40.91B | 6.03 | 19.40% | 4.80% | 0.22% | -38.76% | |
49 Neutral | $8.21B | -4.26 | -18.18% | 4.08% | -4.01% | -339.22% |